Echocardiography-based Motion Integration and Management for Substrate Characterization and STAR Therapy in Ventricular Tachycardias

Launched by UNIVERSITY OF LUEBECK · Jul 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help manage a type of heart rhythm problem called ventricular arrhythmia, which can cause serious issues like rapid heartbeats. Researchers want to see if they can use advanced imaging techniques and artificial intelligence to better understand the heart's structure and motion during a specific treatment called stereotactic arrhythmia radioablation. The goal is to improve how doctors target the areas of the heart that cause these dangerous rhythms.

To be eligible for this trial, participants need to be at least 18 years old and scheduled for a procedure to treat ventricular arrhythmias, which include conditions like ventricular fibrillation and tachycardia. They will also need to undergo a special heart scan before the procedure. However, individuals with certain health conditions, such as a very low or very high body mass index (BMI) or low platelet counts, won't be able to participate. If enrolled, participants can expect to undergo various assessments to collect data that will help improve future treatments for heart rhythm problems.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years
• • Indication for catheter ablation of ventricular arrhythmias (ventricular fibrillation, ventricular tachycardia, premature ventricular contractions)
• • Indication for preprocedural contrast-enhanced cardiac computed tomography for cardiac structure characterization
• Exclusion Criteria:
• • Platelet count \< 100,000 cells/mm3
• • BMI \> 45 kg/m2 or \< 18 kg/m2